AQXP Forecast and Technical Stock Analysis
Sell candidate since 2019-10-14 PDF
Aquinox Pharmaceuticals fell by -4.50% in the last day ( Monday, 14th Oct 2019 ) from $2.89 to $2.76 During the day the stock fluctuated 6.20% from a day low at $2.74 to a day high of $2.91. The price has fallen in 7 of the last 10 days and is down by -3.16% for this period. Volume has increased in the last day by 12 316 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 41 495 shares bought and sold for approximately $114 526.00.
- 30 day high of the AQXP stock price was $3.69 and low was $2.61.
- 90 day high was $4.23 and low was $2.39.
- 52 week high for Aquinox Pharmaceuticals - $4.23 and low - $2.00.
Aquinox Pharmaceuticals lies in the lower part of a very wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.66 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 4.94% during the next 3 months and, with 90% probability hold a price between $2.79 and $4.36 at the end of this period.
There are few to none technical positive signals at the moment. Aquinox Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $2.81 and $3.09. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Friday October 11, 2019, which indicates further falls until a new bottom pivot has been found. Aquinox Pharmaceuticals gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 33 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aquinox Pharmaceuticals finds support from accumulated volume at $2.68.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.17 between high and low, or 6.20%. For the last week, the stock has had a daily average volatility of 10.30%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
10.30 %Average volatility
Very Low Low Medium High Very High
The Aquinox Pharmaceuticals stock holds several negative signals and despite the positive trend we believe Aquinox Pharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|AQXP $2.76 ($-0.13 -4.50%)|
AQXP is down $0.13 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AQXP based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AQXP analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!